The only live, interactive manufacturing capacity compendium for the advanced therapies industry.
In September 2022, we relaunched the Cell & Gene Therapy Manufacturing Capacity Map at Advanced Therapies Europe, highlighting manufacturing capacity across Europe, and commenting on the development of GMP manufacturing space over the preceding years.
We left the London event with an idea to maintain a live, digital resource for the industry to support developers in the identification and research of potential manufacturing partners. Since then, a few iterations later, we are in the position where we are seeking to re-launch the map to better reflect and represent what we’re seeing and hearing from the industry.
For this new version, re-launched with a few pesky bugs ironed out, we are working to pinpoint every location we believe to have cell and gene therapy manufacturing capacity, and invite the industry to support us in developing the map further.
Does your company have manufacturing capacity that’s missing on this map? Is your profile included but missing key details, helpful to those using the map in researching and identifying potential manufacturing partners? Keep us up to date with this form.
Lee Buckler, SVP Advanced Therapies, Blood Centers of America, Advanced Therapies Network, reflects on two decades of working within the advanced therapies industry as Phacilitate celebrates 20 years of operating in the field.